manganese has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Huang, L; Li, L; Lin, Z; Wei, X; Yang, X; Yang, Z; Ye, X | 1 |
| Chang, MQ; Chen, J; Chen, Y; Ding, L; Feng, W; Huang, H; Jia, CX; Song, XR; Wu, R; Zheng, Y | 1 |
| Jiao, J; Li, L; Lu, Y; Ma, Z; Peng, M; Xu, X; Yang, X; Yang, Z; Zhang, R | 1 |
3 other study(ies) available for manganese and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Biodegradable mesoporous manganese carbonate nanocomposites for LED light-driven cancer therapy via enhancing photodynamic therapy and attenuating survivin expression.
Topics: Animals; Antineoplastic Agents; Carbonates; Cell Line, Tumor; Cell Survival; Female; Manganese; Mice; Mice, Nude; Nanocomposites; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Survivin; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2021 |
Manganese-enriched photonic/catalytic nanomedicine augments synergistic anti-TNBC photothermal/nanocatalytic/immuno-therapy via activating cGAS-STING pathway.
Topics: Animals; Catalysis; Humans; Hyperthermia, Induced; Immunotherapy; Manganese; Mice; Nanomedicine; Neoplasms; Nucleotidyltransferases; Triple Negative Breast Neoplasms | 2023 |
A Honeycomb-Like Bismuth/Manganese Oxide Nanoparticle with Mutual Reinforcement of Internal and External Response for Triple-Negative Breast Cancer Targeted Therapy.
Topics: Bismuth; Cell Line, Tumor; Humans; Indocyanine Green; Manganese; Manganese Compounds; Nanoparticles; Oxides; Photochemotherapy; Triple Negative Breast Neoplasms | 2021 |